OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
Dongyao Wang, Zimin Sun, Xiaoyu Zhu, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2788-2804
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35

Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 16

Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis
Biyun Li, Han Yahui, Li Yuanfang, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 5, pp. 601-610
Closed Access | Times Cited: 14

Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia
Cecilia Restelli, Marco Ruella, Luca Paruzzo, et al.
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 234-248
Closed Access | Times Cited: 10

Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9

Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
Bijender Kumar, Anand K. Singh, Rafet Başar, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 764
Closed Access | Times Cited: 8

Structure, unique biological properties, and mechanisms of action of transforming growth factor β
Nataliya Zelisko, Roman Lesyk, Rostyslav Stoika
Bioorganic Chemistry (2024) Vol. 150, pp. 107611-107611
Closed Access | Times Cited: 4

Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Bone marrow immune cells and drug resistance in acute myeloid leukemia
Miao Zhang, You Yang, Jing Liu, et al.
Experimental Biology and Medicine (2025) Vol. 250
Open Access

The rewired immune microenvironment in leukemia
Zoe Ciantra, Varvara Paraskevopoulou, Iannis Aifantis
Nature Immunology (2025)
Closed Access

Critical cardiovascular complications during non-immunosuppressive therapy for VEXAS syndrome
Yuna Saito, Satoshi Suzuki, Keigo Ikeda, et al.
Rheumatology Advances in Practice (2025) Vol. 9, Iss. 2
Open Access

The mouse resource at National Resource Center for Mutant Mice of China
Bingzhou Han, Dongshen Chen, Zhong Chen, et al.
Mammalian Genome (2025)
Open Access

Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemia
Juan Xie, Xuefei Liu, Zhou Tong, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Inhibition of TGF-β signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients
Zhenkun Wang, Zhiwei Zhang, Zhong‐Shi Lyu, et al.
Cancer Letters (2024) Vol. 605, pp. 217290-217290
Closed Access | Times Cited: 3

Nature Killer Cell for Solid Tumors: Current obstacles and prospective remedies in NK cell therapy and beyond
Jia‐Hao Tao, Jun Zhang, Huashun Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104553-104553
Closed Access | Times Cited: 2

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
Jiani Xiao, Tianxiang Zhang, Fei Gao, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5657-5657
Open Access | Times Cited: 9

Natural killer cells in tumor immunotherapy
Dongyao Wang, Haiming Wei
Cancer Biology and Medicine (2023), pp. 1-6
Open Access | Times Cited: 4

Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Huimin Sun, Linjie Wu, Xueying Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming
Zhengmin Wang, Nan Liu, Yang Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Upfront Umbilical Cord Blood Transplantation Versus Immunosuppressive Therapy for Pediatric Patients With Idiopathic Severe Aplastic Anemia
Xuxu Zhao, Wenxiu Lv, Kaidi Song, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 442.e1-442.e13
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top